Diazepam administered intraperitoneally (0.25 mg/kg) enhanced the rate of efflux of [3H]-adenosine and its metabolites from rat cerebral cortex. At a lower dose (0.05 mg/kg), this effect could be detected in only one of four rats. 2 Diazepam (0.05 and 0.25 mg/kg i.p.) depressed acetylcholine release from the rat cerebral cortex. Its effect was reversed by theophylline. 3 Theophylline (15 and 30 mg/kg) enhanced acetylcholine release from the rat cerebral cortex. Diazepam (0.25 mg/kg) administered after theophylline failed to cause a reduction in the rate of release, rather there appeared to be a further enhancement of release. 4 Pentobarbitone sodium (5, 10 and 15 mg/kg i.p.) did not elicit any increase in adenosine release. 5 These results support the proposal that benzodiazepines may exert their pharmacological actions by preventing adenosine uptake, thus enhancing the levels of extracellular adenosine.
Introduction
Although potentiation of the actions of y-aminobutyric acid (Zakusov, Ostrovskaya, Kozhechkin, Marovich, Molodavkin & Voronina, 1977; Karobath & Sperk, 1979; Costa & Guidotti, 1979 ) is believed to be responsible for some of the primary central actions of the benzodiazepines, it has also been suggested that benzodiazepines may act by potentiating the effects of adenosine, a proposed intercellular mediator in the central nervous system (Phillis, 1979) .
Adenosine has a powerful depressant action on the spontaneous activity of neurones in many regions of the brain (Phillis, Kostopoulos & Limacher, 1974; Kostopoulos, Limacher & Phillis, 1975; Kostopoulos & Phillis, 1977) and its release from the cerebral cortex is enhanced by electrical stimulation (Sulakhe & Phillis, 1975) . Diazepam is a potent inhibitor of the uptake of adenosine by brain slices and cultured glial cells (Mah & Daly, 1976; Hertz, Wu & Phillis, 1979) and it potentiates the depressant actions of iontophoretically applied adenosine on rat cerebral cortical neurones (Phillis, 1979) . The depressant effects of flurazepam, a related benzodiazepine, on rat cortical neurones are blocked by the adenosine antagonist, theophylline (Phillis, Edstrom, Ellis & Kirkpatrick, 1979a) , implying either that flurazepam has a direct action on the adenosine receptor or that enhancement of the levels or actions of endogenously released adenosine causes its depressant effects.
Interest in the interactions between benzodiazepines and purines has been intensified by recent 0007-1 188/80/100341-08 $01.00 reports that various purines, including adenosine, inosine and hypoxanthine, can compete for the benzodiazepine-binding site in brain tissue (Skolnick, Marangos, Goodwin, Edwards & Paul, 1978; Marangos, PauL Parma, Goodwin, Syapin & Skolnick, 1979; Asano & Spector, 1979; Damm, Muller & Wollert, 1979) . These studies have been variously interpreted as suggesting that benzodiazepines bind to a purine receptor (Skolnick et al., 1978; Marangos et al., 1979) or to an adenosine transport site (Hertz et al., 1979) .
To obtain in vivo evidence for an action of diazepam at the adenosine transport site, the effect of clinically used doses of this benzodiazepine on adenosine release from the rat cerebral cortex has been ascertained. Furthermore, since it is known that adenosine depresses acetylcholine (ACh) release from the cerebral cortex (Jhamandas & Sawynok, 1976) Phillis & Pinsky, 1971) . At the end of each experiment the hearts were perfused with benzoquinonium chloride (5 x 10-' M) (Mytolon, an AChantagonist)-containing sea water and in every instance the inhibitory effect of the cortical perfusates was abolished.
Results

Adenosine release
The release of labelled adenosine (and its metabolites) from 39 cerebral hemispheres was studied. The amount of labelled material released showed an exponential decline which tended to reach a plateau phase 2 h after the end of incubation. Intraperitoneal drug injections were therefore given 120 min after the start of sample collection (i.e. after removal of the eighth sample).
Diazepam Figure 1 illustrates an experiment in which 0.25 mg/kg of diazepam was administered to the animal. The rate of 3H-efflux declined rapidly from an initial high value and reached a fairly stable level some 75 min after the start of sample collection. Diazepam was injected intraperitoneally at 120 min and evoked a marked increase in the rate of 3H-efflux which was apparent in the next three cortical perfusates. The rate of release of 3H then returned to prediazepam levels.
The results of six such experiments showing the effect of diazepam (0.25 mg/kg) on [3H]-adenosine release from rat cerebral cortex are presented in Table 1 . The mean rate of 3H-efflux during the 7th and 8th samples (those immediately preceding the administration of diazepam) represents the control rate release (100%). During the 30 min period immediately following the administration of diazepam, the rate of efflux of [3H]-adenosine was increased in 9 cortices of 6 rats. The mean percentage increase above control level in these animals was 99.9 + 49 (s.e. mean). During the subsequent 30 min period the mean rate of release from these animals was increased above con- Pentobarbitone sodium Pentobarbitone sodium was administered intraperitoneally in doses of 15 mg/kg (3 rats; 5 cortices) or in an ascending sequence of doses of 5, 10 and 15 mg/kg at 45 min intervals (8 rats; 13 cortices). In these amounts pentobarbitone did not increase 3H-efflux from the cerebral cortex. There was an indication in some experiments that pentobarbitone may actually have depressed [3H]-adenosine release, but the continual decline in release typical of labelled isotope efflux studies such as these, makes it impossible to determine the significance of these observations. The results of one experiment are illustrated in Figure 3 . Pentobarbitone (5, 10 and 15 mg/kg) failed to increase the rate of 3H-efflux from either cortical hemisphere. Similar results were obtained with the other 10 animals. cm-2 in the third post-injection collection period. Release then started to decrease, falling to 1062 pg min-' cm-2 in the fourth collection period and at this point the experiment was terminated.
Discussion
The experiments described in this paper show that diazepam affects the release of acetylcholine and adenosine or its derivatives from the rat cerebral cortex in vivo. Endogenous ACh release was measured by a sensitive and reliable bioassay technique (the Mercenaria mercenaria heart). Adenosine release was measured by prelabelling the endogenous pools with [3H]-adenosine. Following such prelabelling, most of the radioactive marker is associated with adenine nucleotides and adenosine, and only a small proportion of the adenosine is metabolized to inosine, hypoxanthine and adenine (Kuroda & McIlwain, 1974) . After release, the radioactive label output consists mainly of adenosine and its metabolites, inosine and hypoxanthine, with a small amount of labelled nucleotides (Kuroda & McIlwain, 1974; Sulakhe & Phillis, 1975; Lewin & Bleck, 1976) . Diazepam was administered intraperitoneally in doses of 0.05 and 0.25 mg/kg. The latter dose closely approximates the therapeutic dose used by oral or 
Theophylline Diazepam 15mg /kg 0.25mg/kg Figure 5 Rates of acetylcholine (ACh) release from the rat cortex before and after intraperitoneal injections of theophylline (15 mg (Hillestad, Hansen, Melsom & Drivenes, 1974 Diazepam increased the rate of efflux of adenosine and its metabolites from the in situ rat cerebral cortex. Urea release, used as an indicator of non-specific alterations in release, was unaffected, signifying that the alterations in adenosine release reflect a selective effect of this benzodiazepine. The effect is unlikely to have been a consequence of an increase in the depth of anaesthesia and/or subsequent fall in oxygen tension in the brain as no increase in adenosine release was observed after administration of the barbiturate anaesthetic, pentobarbitone sodium, which both deepened anaesthesia and depressed respiration. Our results extend an earlier observation (Lewin & Bleck, 1976 ) that another barbiturate, phenobarbitone, has no effect on adenosine release from brain slices. The adenosine-release enhancing effect of diazepam is probably related to inhibition of adenosine uptake (Mah & Daly, 1976; Hertz et al., 1979) , and is consistent both with the potentiating action of this agent on adenosine-elicited depression of neuronal firing (Phillis, 1979; Phillis, Kostopoulos, Edstrom & Ellis, 1979c) , and the antagonism of flurazepam-evoked depression of neuronal firing by the adenosine antagonist, theophylline (Phillis et al., 1979a) .
Adenosine, applied topically, depresses ACh release from the guinea-pig cerebral cortex and this effect is antagonized by theophylline (Jhamandas & Sawynok, 1976) . Adenosine also depresses ACh release at peripheral cholinergic nerve terminals by a theophyllinesensitive mechanism (Ribeiro, 1978; Ribeiro, Dominguez & Goncalves, 1979) . The depressant action of diazepam on rat cerebral cortical ACh release observed in the present study may therefore be a consequence of its enhancement of extracellular adenosine levels. The suggestion that a purine receptor is involved receives further support from the observation that theophylline, administered either before or after diazepam, abolishes or reverses the depressant effect of the latter on cortical ACh release. Theophylline itself increased cortical ACh release, in sympathy with an earlier observation made on brain slices (Vizi & Knoll 1976) .
Theophylline enhancement of cerebral cortical ACh release is probably a result of actions at several levels of the neural axis. The suggestion has been made elsewhere Phillis, Edstrom, Kostopoulos & Kirkpatrick, 1979b ) that the firing of central neurones is subject to regulation by endogenously released adenosine. Theophylline would increase the rate of ACh release by antagonizing the depressant action of endogenous adenosine. Theophylline is also a central nervous system stimulant; an action probably related to the antagonism of adenosine at many levels of the neural axis, and as such it arouses the brain. Since cortical ACh release is demonstrably affected by the level of arousal (Mullin & Phillis, 1975; Pepeu, 1973) this property of theophylline must also be considered a significant factor in explaining the theophylline-elioited increase in ACh release.
Methylxanthines are also known to be able to mobilize calcium and to favour transmitter release (Johnson & Inesi, 1969; Berkowitz, Tarver & Spector, 1970; Standaert, Dretchen, Skirboll & Morgenroth, 1976) . This could provide an alternative but related explanation for the enhancement of cerebral cortical ACh release by theophylline. The calcium mobilizing effects of theophylline at nerve terminals may yet prove to be a further manifestation of its adenosine antagonist actions, and imply that adenosine stabilizes Ca2 + at nerve terminals.
The possibility that diazepam depresses ACh release non-specifically by augmenting the level of anaesthesia appears to be unlikely for various reasons. Diazepam failed to depress release in theophylline pretreated animals, suggesting that its effects are mediated by an adenosine receptor rather than by non-specific alterations in the depth of anaesthesia. Furthermore when given to unanaesthetized mice, diazepam (5 to 40 mg/kg) increased whole brain ACh levels (Consolo, Ladinsky, Peri & Garattini, 1972 ) the result presumably of a decreased release of ACh.
An interesting finding is the increase in ACh release observed when diazepam was given after theophylline pretreatment. The significance of this observation is uncertain, but it does suggest that diazepam may have more than one action, being capable of both suppressing and enhancing the release of acetylcholine. In this respect there appear to be certain similarities between the actions of diazepam and morphine on ACh release (Phillis, Mullin 4 Pinsky, 1973) .
In conclusion, the results in this paper show that diazepam increases the release of adenosine and its metabolites and depresses the release of ACh from rat cerebral cortex. Its effects on ACh release are abolished by the adenosine antagonist, theophylline. The most plausible explanation for these observations is that diazepam enhances adenosine release by blocking its re-uptake into neuronal and glial cells and that the depression of ACh release is a consequence of these enhanced levels of extracellular adenosine. Adenosine also depresses monoamine release from central and peripheral nerve terminals (Ribeiro, 1978) and a depressant effect of the benzodiazepines on transmitter release at such junctions is to be anticipated. These effects of the benzodiazepines, perhaps in conjunction with a potentiation of the actions of yaminobutyric acid, could account for their anxiolytic, anticonvulsant and muscle relaxant actions.
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